Showing 19,861 - 19,880 results of 100,782 for search '(( 5 non decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.30s Refine Results
  1. 19861
  2. 19862

    Age at treatment initiation–cross sex hormones. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  3. 19863

    Study characteristics. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  4. 19864

    Age at treatment initiation–puberty suppression. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  5. 19865

    Search terms. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  6. 19866

    PRISMA diagram. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  7. 19867

    PRISMA 2020 checklist. by Lucy Thompson (3705940)

    Published 2023
    “…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
  8. 19868
  9. 19869
  10. 19870

    Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model - Fig 5 by Anna Curry (3778423)

    Published 2017
    “…<p>A. WT, CD200<sup>-/-</sup>, and CD200R<sup>-/-</sup> BALB/c mice received 5x10<sup>5</sup> EMT6 tumor cells injected into the mammary fat pad. 15 days later tumors were surgically resected and mice were immunized with irradiated EMT6 cells and CpG as adjuvant [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0171586#pone.0171586.ref004" target="_blank">4</a>]. …”
  11. 19871
  12. 19872
  13. 19873
  14. 19874
  15. 19875
  16. 19876
  17. 19877
  18. 19878

    Table_5_PpSAUR5 promotes plant growth by regulating lignin and hormone pathways.xls by Xin-Miao Li (18876931)

    Published 2024
    “…Future studies can use PpSAUR5 as a candidate gene to elucidate the potential regulatory mechanisms underlying peach tree vigor.…”
  19. 19879
  20. 19880